(Yicai Global) Nov. 7 -- A total of 21 Chinese hospitals placed orders for the Da Vinci Robotic Surgical System, worth more than USD60 million, with US supplier Intuitive Surgical yesterday on the second day of the China International Import Expo in Shanghai.
The system is one of the world's leading minimally invasive surgical robots. The robot was originally designed for wartime remote operations. Doctors can do surgery by just sitting in front of a console. The robot arm takes corresponding action, replacing manual operation. Da Vinci surgical robots are more accurate and stable compared with traditional surgery.
But the surgical robot comes at a steep cost, with prices ranging between USD600,000 and USD2.5 million.
The surgical robot first entered China in 2014, with more than 70 now in use on the Chinese mainland and 10 in Hong Kong.
The robot's average usage per single machine in China has repeatedly broken world records, public data shows. China's annual average usage count per single machine was 394 in 2017. China's mainland boasts 45 hospitals with single machine usage count of over 250 while the world's top eight hospitals are all in China. The First Affiliated Hospital of Nanchang University, the First Affiliated Hospital of Zhejiang University and People's Liberation Army General Hospital rank as the world's top three.
Intuitive Surgical and Shanghai-based Foshun Pharmaceutical formed a joint venture in May last year. The joint venture will focus on the promotion of Da Vinci surgical robots in China. The two sides will also work together to develop, produce and sell products for early diagnosis and treatment of lung cancer.